129. Our position remains unchanged. I would like to reiterate that IP protection for biological inventions will ultimately contribute to improvement in welfare, particularly in agriculture and health sectors. Regarding the relationship between the TRIPS Agreement and the Convention on Biological Diversity (CBD), we are of the view that the objective and jurisdiction of the two agreements are separate, therefore it is unnecessary to amend the TRIPS Agreement. Lastly, in order to avoid the duplication of discussion, we believe the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC) is the right forum to discuss this issue.
130. Regarding Ukraine's statement, we would like to echo previous speakers in supporting Ukraine and condemning the Russian Federation's illegal attacks.